Cure My Disease

Don't miss your cure!

 Log in / Sign up

New digital program aims to tame bipolar mood swings

NCT ID NCT07239778

Disease control Sponsor: Oslo University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 04, 2026 · Updated 2 times

Summary

This study tests a new group program called PEDAL for people with bipolar disorder. It combines standard group education with digital tools like an app-based mood diary and online resources to help manage rapid mood swings. The trial will involve 120 participants across five sites in Norway. Researchers want to see if PEDAL reduces mood instability better than standard group education alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
group psychoeducation with digital tools and mood diary
What this could lead to
If it works, this could offer a more effective way to manage rapid mood swings in bipolar disorder, improving daily stability and quality of life.
What could go wrong
This is a Phase 2 trial with only 120 participants, so results may not apply to everyone. The added digital tools may not provide extra benefit over standard group education.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Bipolar I, II or not otherwise specified disorder * Understands Scandinavian language * Owns and will use smartphone as part of the intervention * Is considered eligible for group participation by treating clinician Exclusion Criteria: * Previous participation in group psychoeducation for bipolar disorder * Will move, is late in pregnancy or other situation that prevents competion of trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bipolar disorder (BD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder Emotional Regulation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bipolar disorder (BD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Diakonhjemmet Hospital (Allmennpsykiatrisk poliklinikk)

    RECRUITING

    Oslo, 0373, Norway

  • Lovisenberg Diaconal Hospital (Section for Group Treatment)

    RECRUITING

    Oslo, 0440, Norway

  • Oslo University Hospital (Nydalen DPS and Søndre Oslo DPS)

    RECRUITING

    Oslo, 0351, Norway

  • Vestre Viken Hospital Trust (Drammen DPS)

    RECRUITING

    Drammen, 3018, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.